President John Dramani Mahama has announced plans to establish a vaccine production hub in Ghana to strengthen the country’s pharmaceutical industry, boost local medicine manufacturing and reduce dependence on imported medical supplies.
The initiative forms part of the government’s broader strategy to create jobs, expand local pharmaceutical production and position Ghana as a leading destination for vaccine and medicine manufacturing in Africa.
Speaking during a courtesy call by chiefs from the Western North Region, President Mahama said the COVID-19 pandemic exposed Africa’s reliance on foreign countries for essential vaccines and medicines, highlighting the need to develop domestic production capacity.
The President explained that the government is pursuing initiatives under the proposed Accra Reset agenda to promote health sovereignty, improve healthcare investment and reduce dependence on external suppliers.
He recalled that African countries faced challenges accessing COVID-19 vaccines during the pandemic, stressing the importance of ensuring that Ghana and other African nations can manufacture essential medical products locally.
President Mahama reaffirmed his commitment to strengthening Ghana’s healthcare system, supporting pharmaceutical companies and building local capacity to respond effectively to future public health emergencies.
The proposed vaccine manufacturing hub is expected to support Ghana’s pharmaceutical sector, create employment opportunities and contribute to long-term healthcare security, although implementation details and the project timeline have not been provided in the announcement.
Source: newsthemegh.com